Factors | Overall survival | ||||
---|---|---|---|---|---|
Number | Mean(years) | 95% CI | χ 2 | P | |
All patients | 136 | 9.5 | 8.1-11.0 | ||
Sex | 2.053 | 0.152 | |||
Female | 54 | 9.9 | 8.5-11.3 | ||
Male | 82 | 8.7 | 6.7-10.6 | ||
Age | 0.259 | 0.611 | |||
≤50 | 60 | 9.9 | 8.0-11.8 | ||
>50 | 76 | 7.8 | 5.9-9.6 | ||
Site | 2.385 | 0.123 | |||
Gastrointestinaltract | 77 | 6.7 | 5.4-8.0 | ||
Pancreas | 46 | 11.1 | 9.3-12.9 | ||
Functional status | 6.691 | 0.006 | |||
Functional | 22 | NR | NC | ||
Nonfunctional | 114 | 7.7 | 6.1-9.2 | ||
Tumor grading | 9.087 | 0.011 | |||
G1 | 63 | 10.8 | 8.7-12.9 | ||
G2 | 25 | 3.5 | 2.6-4.3 | ||
G3 | 41 | 4.1 | 2.8-5.4 | ||
Tumor type | 6.634 | 0.010 | |||
NET | 88 | 10.1 | 8.1-12.1 | ||
NEC + MANEC | 41 | 4.1 | 2.8-5.4 | ||
Distant metastasis | 23.773 | 0.000 | |||
Yes | 44 | 5.0 | 2.7-7.3 | ||
No | 92 | 11.0 | 9.2-12.8 |